Titre:
  • Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
Auteur:Ding, Lei; Gysemans, Conny A; Stangé, Geert; Heremans, Yves; Yuchi, Yixing; Takiishi, Tatiana; Korf, Hannelie; Chintinne, Marie; Carr, Richard D; Heimberg, Harry; Pipeleers, Daniel; Mathieu, Chantal
Informations sur la publication:PloS one, 9, 9, page (e107935)
Statut de publication:Publié, 2014
Sujet CREF:Diabétologie
Immunologie
Endocrinologie
Biologie cellulaire
Biologie
MeSH keywords:Animals
Antibodies, Monoclonal -- pharmacology
CD3 Complex -- genetics -- immunology
CD8-Positive T-Lymphocytes -- drug effects -- immunology -- pathology
Cricetinae
Diabetes Mellitus, Type 1 -- drug therapy -- immunology -- pathology
Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
Drug Synergism
Drug Therapy, Combination
Hypoglycemic Agents -- pharmacology
Insulin-Secreting Cells -- drug effects -- immunology -- pathology
Lymph Nodes -- drug effects -- immunology -- pathology
Mice
Mice, Inbred NOD
Pancreas -- drug effects -- immunology -- pathology
Remission Induction
Spleen -- drug effects -- immunology -- pathology
T-Lymphocytes, Regulatory -- drug effects -- immunology -- pathology
Langue:Anglais
Identificateurs:urn:issn:1932-6203
info:doi/10.1371/journal.pone.0107935
info:pii/PONE-D-14-23730
info:pmid/25268801
PMC4182446